Ninga Desmond

These boys successfully finished their exams yesterday, I’m happy for you guys.
Wishing you all an excellent result. Can’t wait to see you at the clinic

Have you seen a handsome guy today?

In the presence of the lord

🧠 Amyotrophic Lateral Sclerosis (ALS): Clinical Pathophysiology, Classification, and Advanced Physiotherapy Interventions

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease or Motor Neuron Disease, is a progressive neurodegenerative disorder involving the degeneration of both upper motor neurons (UMN) in the motor cortex and lower motor neurons (LMN) in the brainstem and spinal cord. It leads to muscle weakness, atrophy, spasticity, and eventual paralysis, with respiratory failure as the most common cause of death. ALS is the most common adult-onset motor neuron disease, with average survival of 2–5 years from symptom onset, though 10% may live longer. It affects people worldwide, typically in the 50–70 age group, with slight male predominance in sporadic cases.

Effective management is multidisciplinary, focusing on symptom relief, maintaining function and quality of life, respiratory support, nutrition, and palliative care. No cure exists, but disease-modifying drugs (riluzole, edaravone) offer modest benefits. Physiotherapy plays a central role in preserving mobility, preventing complications, managing spasticity and pain, and supporting respiratory function.

⚖️ The Biomechanical & Neurological Breakdown

Core Pathophysiology

Selective degeneration of UMN (Betz cells in motor cortex and corticospinal tracts) and LMN (anterior horn cells in spinal cord and cranial nerve nuclei).

This results in a combination of UMN signs (spasticity, hyperreflexia, Babinski sign) and LMN signs (muscle weakness, atrophy, fasciculations, hyporeflexia).

Pathological hallmarks include TDP-43 protein aggregates, mitochondrial dysfunction, oxidative stress, excitotoxicity (glutamate toxicity), impaired axonal transport, and neuroinflammation with glial activation.

The disease spreads contiguously from the site of onset to adjacent regions. Eye movements, bladder, and bowel functions are usually spared until late stages.

Common Risk Factors & Etiology

Sporadic (90–95%) vs familial (5–10%, often linked to C9orf72, SOD1, TARDBP, FUS mutations).

Age, male s*x, smoking, military service, and possible environmental exposures (pesticides, heavy metals).

No single cause; complex gene-environment interaction.

These changes cause progressive loss of voluntary muscle control, reduced force generation, fatigue, and secondary issues like joint contractures, postural instability, and respiratory muscle weakness.

💪 Clinical Features & Neurological Indicators

Symptoms usually begin focally and spread:

Limb-onset (most common, ~65–70%): Distal weakness, foot drop, hand clumsiness, tripping, difficulty with fine motor tasks.

Bulbar-onset (~25–30%): Dysarthria, dysphagia, sialorrhea, tongue fasciculations — often faster progression.

Respiratory-onset (rare, ~5%): Early breathing difficulty.

Mixed UMN + LMN Signs

LMN: Muscle atrophy, fasciculations, cramps, flaccid weakness.

UMN: Spasticity, brisk reflexes, clonus, pathological signs.

Other: Fatigue, weight loss, pseudobulbar affect (emotional lability), mild cognitive/behavioral changes (in ~15–50%, sometimes overlapping with frontotemporal dementia).

Progression is variable but relentless, leading to loss of ambulation, speech, swallowing, and independent breathing. Pain, joint stiffness, and falls are common secondary problems.

Stages of Progression (often described functionally rather than rigid stages):

Early: Mild focal weakness, preserved independence.

Middle: Increasing weakness, need for assistive devices, emerging bulbar/respiratory issues.

Late: Severe disability, dependence on caregivers, non-invasive or invasive ventilation, feeding tube.

ALSFRS-R (Revised ALS Functional Rating Scale) — gold standard tool (12 items, max 48 points) assessing bulbar, fine motor, gross motor, and respiratory function. Rate of decline helps predict prognosis.

🔍 Clinical Assessment & Classification

Diagnosis is primarily clinical, supported by electromyography (EMG) showing widespread denervation and reinnervation. MRI and blood tests rule out mimics (cervical myelopathy, multifocal motor neuropathy, etc.).

Diagnostic Criteria

Revised El Escorial or Awaji criteria (higher sensitivity).

Newer Gold Coast criteria: Simpler — progressive weakness with UMN + LMN signs in at least one region (or LMN in two regions), excluding alternatives.

Classification

By region of onset: Limb, bulbar, respiratory.

By predominant signs: Classic ALS (mixed UMN/LMN), Primary Lateral Sclerosis (pure UMN), Progressive Muscular Atrophy (pure LMN), Flail arm/leg variants.

Sporadic vs familial.

With or without cognitive involvement (ALS-FTD spectrum).

Key Assessments for Physiotherapy:

ALSFRS-R for overall function.
Muscle strength (MRC scale), range of motion, spasticity (Modified Ashworth Scale).

Gait and balance analysis, Timed Up & Go, 6-Minute Walk Test (when possible).

Respiratory: Forced Vital Capacity (FVC), Sniff Nasal Inspiratory Pressure (SNIP), cough effectiveness.

Pain, fatigue, and quality-of-life measures.
Early and accurate assessment enables timely intervention and equipment prescription.

🏥 Evidence-Based Physiotherapy Management

Physiotherapy in ALS is highly valuable for maintaining function, preventing secondary complications, and improving quality of life. The focus is not on strengthening weakened muscles aggressively (to avoid overuse fatigue) but on preserving remaining function, flexibility, safety, and respiratory capacity through moderate, individualized, supervised programs. Evidence supports tailored exercise without causing harm when properly dosed.

Early & Maintenance Phase

Gentle to moderate aerobic exercise (stationary bike, walking, aquatic therapy) to maintain cardiopulmonary fitness and reduce deconditioning.

Stretching and range-of-motion (active, assisted, or passive) to prevent contractures and joint stiffness.

Low-to-moderate resistance training for less-affected muscles to support overall function.

Balance and gait training with appropriate aids (ankle-foot orthoses for foot drop, canes/walkers).

Functional Training & Symptom Management
Fall prevention strategies, home modifications, energy conservation techniques.

Transfer training and safe mobility techniques for patients and caregivers.

Spasticity management: Stretching, positioning, splinting.

Pain relief through positioning, massage, and modalities as needed.

Respiratory physiotherapy: Early breathing exercises, cough augmentation techniques, inspiratory muscle training (when appropriate and supervised), postural drainage.

Advanced & Long-Term Strategies

Prescription of assistive devices: Wheelchairs, power mobility, neck collars, communication aids (in coordination with OT/SLT).

Respiratory support preparation: Training for non-invasive ventilation (NIV) tolerance.

Caregiver education on safe handling, stretching programs, and lifting techniques.

Palliative focus in late stages: Maintaining comfort, preventing pressure sores, passive movements.

Moderate supervised exercise (aerobic + functional) is safe and can improve or stabilize function, reduce fatigue, and enhance quality of life. High-intensity or eccentric training should generally be avoided. Multidisciplinary ALS clinics show better outcomes.

🎯 Clinical Conclusion

Amyotrophic Lateral Sclerosis is a devastating progressive motor neuron disease causing combined UMN and LMN degeneration, leading to widespread muscle weakness, atrophy, and eventual respiratory failure. While incurable, early diagnosis using clinical criteria and EMG, combined with disease-modifying medications and comprehensive multidisciplinary care, can meaningfully extend quality of life and independence.

Physiotherapy plays a major, evidence-based role throughout the disease course by focusing on maintaining mobility, preventing contractures and falls, supporting respiratory function, managing spasticity and pain, and empowering patients and caregivers with adaptive strategies. Individualized, moderate-intensity programs emphasizing stretching, functional training, energy conservation, and timely assistive devices are key to optimizing function and participation.
The best outcomes occur in specialized multidisciplinary teams (neurologist, physiotherapist, occupational therapist, speech-language therapist, respiratory therapist, dietitian, and palliative care). Ongoing research into exercise dosing, respiratory training, and novel therapies continues to improve care for people living with ALS.





Credit: Dr Arslan Sukhera PT

Fear short ladies
I repeat, fear short girls🙄